Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in

MedCap AB (publ)
STO:MCAP

Watchlist Manager
MedCap AB (publ) Logo
MedCap AB (publ)
STO:MCAP
Watchlist
Price: 530 SEK 0.38% Market Closed
Market Cap: kr8B
Write Note Create Alert Ask AI

Wall St Price Targets

MCAP Price Targets Summary
MedCap AB (publ)

Wall Street analysts forecast MCAP stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MCAP is 652.8 SEK with a low forecast of 626.2 SEK and a high forecast of 693 SEK.

MCAP Lowest Forecast
Wall Street Target
kr626.2
18% Upside
MCAP Average Forecast
Wall Street Target
kr652.8
23% Upside
MCAP Highest Forecast
Wall Street Target
kr693
31% Upside
Lowest Forecast
Price Target
626.2 SEK
18% Upside
Average Forecast
Price Target
652.8 SEK
23% Upside
Highest Forecast
Price Target
693 SEK
31% Upside
MedCap AB (publ) Competitors:
Price Targets

Revenue
Forecast

17% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
17% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 7 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 3 years is 12%.

What are analyst estimates?

Gross Profit
Forecast

25% / Year
Past Growth
13% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
25% / Year
Past Growth
13% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 7 years, the compound annual growth rate for Gross Profit has been 25%. The projected CAGR for the next 3 years is 13%.

What are analyst estimates?

Operating Income
Forecast

33% / Year
Past Growth
17% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss
33% / Year
Past Growth
17% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Over the last 7 years, the compound annual growth rate for Operating Income has been 33%. The projected CAGR for the next 3 years is 17%.

What are analyst estimates?

Pre-Tax Income
Forecast

33% / Year
Past Growth
18% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss
33% / Year
Past Growth
18% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Over the last 7 years, the compound annual growth rate for Pre-Tax Income has been 33%. The projected CAGR for the next 3 years is 18%.

What are analyst estimates?

Net Income
Forecast

132% / Year
Past Growth
18% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss
132% / Year
Past Growth
18% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Over the last 7 years, the compound annual growth rate for Net Income has been 132%. The projected CAGR for the next 3 years is 18%.

What are analyst estimates?

Continue MCAP Research

Summary
MCAP intrinsic value, competitors valuation, and company profile.
DCF Valuation
MCAP stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MCAP stock valuation using valuation multiples.
Wall St Estimates
MCAP price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MCAP stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other MedCap AB (publ) listings:
F • EUR
61MA
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is MCAP's stock price target?
Price Target
652.8 SEK

According to Wall Street analysts, the average 1-year price target for MCAP is 652.8 SEK with a low forecast of 626.2 SEK and a high forecast of 693 SEK.

What is the Revenue forecast for MedCap AB (publ)?
Projected CAGR
12%

Over the last 7 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 3 years is 12%.

What is the Gross Profit forecast for MedCap AB (publ)?
Projected CAGR
13%

Over the last 7 years, the compound annual growth rate for Gross Profit has been 25%. The projected CAGR for the next 3 years is 13%.

What is the Operating Income forecast for MedCap AB (publ)?
Projected CAGR
17%

Over the last 7 years, the compound annual growth rate for Operating Income has been 33%. The projected CAGR for the next 3 years is 17%.

What is the Pre-Tax Income forecast for MedCap AB (publ)?
Projected CAGR
18%

Over the last 7 years, the compound annual growth rate for Pre-Tax Income has been 33%. The projected CAGR for the next 3 years is 18%.

What is the Net Income forecast for MedCap AB (publ)?
Projected CAGR
18%

Over the last 7 years, the compound annual growth rate for Net Income has been 132%. The projected CAGR for the next 3 years is 18%.

Back to Top
ALPHA SPREAD
Follow us
Join 358,200+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.